Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gout Flares”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Early research (Phase 1)Study completedNCT06258213
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral ABP-745 Administration in Healthy Volunteers

Who this might be right for
GoutAcute Gout FlareGout Flares
Atom Therapeutics Co., Ltd 90
Large-scale testing (Phase 3)Ended earlyNCT01362608
What this trial is testing

Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective

Who this might be right for
Gouty Arthritis
Novartis Pharmaceuticals 136
Post-approval studies (Phase 4)Study completedNCT00170781
What this trial is testing

Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout

Who this might be right for
Acute Gouty Arthritis
Novartis 234
Post-approval studies (Phase 4)Looking for participantsNCT07346079
What this trial is testing

Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares

Who this might be right for
Gout ArthritisGout FlareGout
Massachusetts General Hospital 150
Large-scale testing (Phase 3)Study completedNCT00856206
What this trial is testing

Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE)

Who this might be right for
Gout
Regeneron Pharmaceuticals 1,315
Not applicableNot Yet RecruitingNCT06669000
What this trial is testing

Time Required to Dissolve Urate Deposits

Who this might be right for
Gout
Assistance Publique - Hôpitaux de Paris 250
Testing effectiveness (Phase 2)Study completedNCT05936281
What this trial is testing

The Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202)

Who this might be right for
GoutGout Initiating Urate-loweringUrate-lowering Therapy
Changchun GeneScience Pharmaceutical Co., Ltd. 165
Testing effectiveness (Phase 2)Study completedNCT00798369
What this trial is testing

Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients

Who this might be right for
Acute Gout
Novartis 200
Large-scale testing (Phase 3)Study completedNCT01356602
What this trial is testing

Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients

Who this might be right for
Acute Gouty Arthritis
Novartis Pharmaceuticals 397
Large-scale testing (Phase 3)Study completedNCT01431638
What this trial is testing

Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients

Who this might be right for
Acute Gouty Arthritis
Novartis Pharmaceuticals 397
Not applicableStudy completedNCT02855437
What this trial is testing

Novel Methods for Ascertainment of Gout Flares -A Pilot Study

Who this might be right for
Gout
University of Alabama at Birmingham 44
Large-scale testing (Phase 3)Study completedNCT00829829
What this trial is testing

PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1

Who this might be right for
Intercritical Gout
Regeneron Pharmaceuticals 241
Early research (Phase 1)Study completedNCT06444867
What this trial is testing

Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968

Who this might be right for
Joint PainGout FlaresJoint Inflammation
LEO Pharma 6
Large-scale testing (Phase 3)Study completedNCT01029652
What this trial is testing

Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine Including a 12 Weeks Extension and an Open-label 48 Weeks Extension Study

Who this might be right for
Acute Gout
Novartis Pharmaceuticals 230
Large-scale testing (Phase 3)Study completedNCT01080131
What this trial is testing

Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study.

Who this might be right for
Acute Gout
Novartis Pharmaceuticals 226
Large-scale testing (Phase 3)Study completedNCT00958438
What this trial is testing

PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations (PRE-SURGE 2)

Who this might be right for
Gout
Regeneron Pharmaceuticals 248
Testing effectiveness (Phase 2)Looking for participantsNCT07145229
What this trial is testing

Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

Who this might be right for
Acute Gouty ArthritisGout FlareGout Flares+1 more
Atom Therapeutics Co., Ltd 380
Not applicableUnknownNCT05744297
What this trial is testing

NLRP3 Inflammasome Activation Among Patients During Acute Gout Flares

Who this might be right for
Gout Arthritis
Centre Hospitalier Saint Joseph Saint Luc de Lyon 10
Large-scale testing (Phase 3)Study completedNCT01470989
What this trial is testing

Β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)

Who this might be right for
Acute Gouty Arthritis Flares
Novartis Pharmaceuticals 136
Testing effectiveness (Phase 2)Study completedNCT02063997
What this trial is testing

Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients

Who this might be right for
Gout
Gilead Sciences 248
Load More Results